Skip to main content
. 2024 Sep 4;16(3):297–305. doi: 10.4274/jcrpe.galenos.2024.2023-10-16

Table 2b. Treatment.

Treatment

HNF4A

n=8

GCK

n=146

HNF1A

n=43

Lecture

Diet

SU

GLP-1 RA

Insulin

Diet

SU

Meglitinide,

GLP-1 RA, SGLT-2

Insulin

In our cases

D: 4

SU: 2

Intensive ins: 2

D: 135

SU: 3

OAD (M): 3

Insulin: 2

Intensive ins: 3

D: 13

OAD (S): 11

OAD (M): 4

ins: 7

Basal ins+OAD: 2

OAD: oral anti-diabetic, M: metformin, D: diet, SU: sulphonylureas, GLP-1 RA: glucagon-like peptide 1 receptor agonist, SGLT-2: sodium-glucose transport protein 2 inhibitors, ins: insuline